Скачать или смотреть Diagnostic Impact of 18F-FDG PET/MRI vs PET/CT in Histiocytosis | Medical Symposium Barcelona 2025

This presentation, delivered by Pudis Michal of Hospital Universitari de Bellvitge, Barcelona, Spain, explores the diagnostic value of 18F-FDG PET/MRI compared to PET/CT in histiocytoses. As part of the Medical Symposium held on May 27, 2025, in Barcelona, this prospective comparative study provides new insights into how PET/MRI technology may enhance diagnostic accuracy and clinical decision-making for patients with histiocytic disorders.

The lecture was featured on Day Two of the international medical symposium, where leading experts gathered to discuss cutting-edge advances in molecular imaging, diagnostics, and clinical applications. The session emphasizes the role of hybrid imaging techniques in rare diseases, the advantages of PET/MRI over traditional PET/CT, and how these findings can influence patient management and outcomes.

Viewers will gain a deeper understanding of the comparative methodology, study results, and clinical implications, making this video a valuable resource for nuclear medicine specialists, radiologists, oncologists, and researchers interested in imaging innovations for complex diseases.

Stay tuned for more presentations from the symposium agenda, highlighting the latest breakthroughs in imaging, diagnosis, and treatment across a range of conditions.